Daniel J. Hoeppner

Daniel J. Hoeppner

Auto-generated profile, based on publicly available information

Daniel J. Hoeppner

Astellas Pharma Inc., Tsukuba, Ibaraki, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2016 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MLMing Li
Ming Li
AJAndrew E Jaffe
Andrew E Jaffe
RSRichard E Straub
Richard E Straub
RTRan Tao
Ran Tao
JSJoo Heon Shin
Joo Heon Shin
DWDaniel R Weinberger
Daniel R Weinberger

1 January 2008
Verified
Book Chapter
Closed access
PDF file
AAAndreas Androutsellis-Theotokis
Andreas Androutsellis-Theotokis
SMSachiko Murase
Sachiko Murase
JBJustin D. Boyd
Justin D. Boyd
DPDeric M. Park
Deric M. Park
DHDaniel J. Hoeppner
Daniel J. Hoeppner
RMRonald D.G. McKay
Ronald D.G. McKay

15 April 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MNMitsuteru Nakamura
Mitsuteru Nakamura
KYKenny Ye
Kenny Ye
MSMariel Barbachan e Silva
Mariel Barbachan e Silva
TYTakahira Yamauchi
Takahira Yamauchi
DHDaniel J. Hoeppner
Daniel J. Hoeppner
NHNoboru Hiroi
Noboru Hiroi
Autism spectrum disorder (ASD) is often signaled by atypical cries during infancy. Copy number variants (CNVs) provide genetically identifiable cases of ASD, but how early atypical cries predict a later onset of ASD among CNV carriers is not understood in humans. Genetic mouse models of CNVs have provided a reliable tool to experimentally isolate the impact of CNVs and identify early predictors for later abnormalities in behaviors relevant to ASD. However, many technical issues have confounded the phenotypic characterization of such mouse models, including systematically biased genetic backgrounds and weak or absent behavioral phenotypes. To address these issues, we developed a coisogenic mouse model of human proximal 16p11.2 hemizygous deletion and applied computational approaches to identify hidden variables within neonatal vocalizations that have predictive power for postpubertal dimensions relevant to ASD. After variables of neonatal vocalizations were selected by least absolute shrinkage and selection operator (Lasso), random forest, and Markov model, regression models were constructed to predict postpubertal dimensions relevant to ASD. While the average scores of many standard behavioral assays designed to model dimensions did not differentiate a model of 16p11.2 hemizygous deletion and wild-type littermates, specific call types and call sequences of neonatal vocalizations predicted individual variability of postpubertal reciprocal social interaction and olfactory responses to a social cue in a genotype-specific manner. Deep-phenotyping and computational analyses identified hidden variables within neonatal social communication that are predictive of postpubertal behaviors.

17 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAtsuo Kanno
Atsuo Kanno
TKTakuya Kito
Takuya Kito
MMMasashi Maeda
Masashi Maeda
SYShanni Yamaki
Shanni Yamaki
YAYasushi Amano
Yasushi Amano
MMMitsuyuki Matsumoto
Mitsuyuki Matsumoto
Anti-NMDA receptor (NMDAR) encephalitis is a devastating disease with severe psychiatric and neurological symptoms believed to be caused by pathogenic autoantibodies that bind to the N-terminal domain (NTD) of the NMDAR GluN1 subunit (GluN1-NTD) crosslinking adjacent NMDARs and driving their internalization. Here we describe ART5803, a humanized monovalent antibody, as a potential therapy for anti-NMDAR encephalitis. ART5803 binds with a high affinity (KD = 0.69 nM) to GluN1-NTD without affecting NMDAR activity or inducing internalization. ART5803 blocks NMDAR internalization induced by patients’ pathogenic autoantibodies, and restores NMDAR function. A marmoset animal model was developed using sustained intracerebroventricular (ICV) administration of a human pathogenic autoantibody to evoke behavioral and motor abnormalities. ART5803 ICV infusion or peripheral injections rapidly reversed these abnormalities. These data, together with the pharmacokinetic profile in cynomolgus monkeys, indicate a therapeutic potential for intravenous (IV)-administered ART5803 as a fast-acting and efficacious option for anti-NMDAR encephalitis.

31 July 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
EBEe Burke
Ee Burke
JCJoshua G Chenoweth
Joshua G Chenoweth
JSJoo Heon Shin
Joo Heon Shin
LCLeonardo Collado-Torres
Leonardo Collado-Torres
SKSuel Kee Kim
Suel Kee Kim
AJAndrew E Jaffe
Andrew E Jaffe
Summary: Human induced pluripotent stem cells (hiPSCs) are a powerful model of neural differentiation and maturation. We present a hiPSC transcriptomics resource on corticogenesis from 5 iPSC donor and 13 subclonal lines across nine time points over 5 broad conditions: self-renewal, early neuronal differentiation, neural precursor cells (NPCs), assembled rosettes, and differentiated neuronal cells that were validated using electrophysiology. We identified widespread changes in the expression of individual transcript features and their splice variants, gene networks, and global patterns of transcription. We next demonstrated that co-culturing human NPCs with rodent astrocytes resulted in mutually synergistic maturation, and that cell type-specific expression data can be extracted using only sequencing read alignments without potentially disruptive cell sorting. We lastly developed and validated a computational tool to estimate the relative neuronal maturity of iPSC-derived neuronal cultures and human brain tissue, which were maturationally heterogeneous but contained subsets of cells most akin to adult human neurons.